Navigation Links
Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
Date:1/14/2009

pproximately 750 patients are expected to be enrolled in Europe, Asia, South America and Canada.

For more information on the ALSYMPCA trial, please go to http://www.algeta.com and click on the ALSYPMCA link in the menu bar.

About Algeta

Algeta ASA is a cancer therapeutics company built on world-leading, proprietary technology. Algeta is developing new, targeted cancer therapeutics that harness the unique characteristics of alpha particle emitters and are potent, well-tolerated and convenient to use.

Algeta's lead product candidate, Alpharadin (based on radium-223), has blockbuster potential for treating bone metastases arising from multiple major cancer types, owing to its bone-targeting nature, potent efficacy (therapeutic and palliative) and benign, placebo-like safety profile. Development of Alpharadin is most advanced targeting bone metastases resulting from hormone-refractory prostate cancer (HRPC), and it entered an international phase III clinical trial (ALSYMPCA) in mid-2008 based on compelling clinical results from a comprehensive phase II program.

Algeta's strategy is to launch Alpharadin as a first or second line treatment for cancer patients with bone metastases either alone or in combination with current standard of care therapies, thereby maximizing its commercial potential.

Algeta is also developing other technologies for delivering alpha emitters. These include microparticles, liposomes, and methods to enhance the potency of therapeutic antibodies and other tumor-targeting molecules by linking them to the alpha particle emitter thorium-227. The Company is headquartered in Oslo, Norway, and was founded in 1997. Algeta listed on the Oslo Stock Exchange in March 2007 (Ticker: ALGETA).

Alpharadin and Algeta are trademarks of Algeta ASA.

About Bone Metastases

Bo
'/>"/>

SOURCE Algeta
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
2. MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
5. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
6. Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma
7. Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia
8. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
9. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
10. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
11. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Scott Steiger lives in St. ... an engineer for the past 20 years, he,s traveled extensively and ... He,s been to six of the seven continents. Travel is a ... http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 So ... pretty good idea of what,s required. His latest creation ...
(Date:11/26/2014)... -- A hernia is condition in which a ... wall of a weak muscle area. Obesity, poor nutrition, smoking, ... the causes of hernias. There are several types of hernia ... hernia is when part of the abdominal tissue/organ protrudes into ... area of the umbilicus. A hiatal hernia is when a ...
(Date:11/26/2014)...  CARsgen, a leader in the development of Chimeric ... variety of cancers, today announced the completion of a ... China -based healthcare private equity fund.   ... development of new therapeutics for liver, lung, stomach and ... Shanghai Renji Hospital, the company plans to initiate clinical ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4CARsgen Completes Series A Financing 2
... and Company,(NYSE: LLY ), strongly disagrees with ... Connecticut Attorney General Richard Blumenthal,in a news release ... content of the release is a disservice to ... a life-threatening disease.,Specifically, the news release contained no ...
... a Hint of a Mutation,s Ancestral African Origin -, ... another group,s discovery of an important gene,associated with obesity, ... DNA that may be more helpful in identifying this ... finding suggests that,the gene variant, identified in DNA from ...
Cached Medicine Technology:Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 2Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 3Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 4Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3
(Date:11/28/2014)... UWDress.com sells cheap tall cocktail ... greatly discounted dresses. Today, there is a new collection ... these dresses are offered at very low prices. It ... in the promotion launched by UWDress.com , UWDress.com is ... world, so the company has the power to ensure ...
(Date:11/28/2014)... November 28, 2014 The month of December ... 20,000 car accidents occurring in Florida every year in December ... importance of auto insurance policies. , "Optional auto insurance coverage ... insurance is not cheap I know, actually Florida is among ... are even higher, but what I see is that the ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Pathways ... December 2, 2014. This national movement was created to ... by giving to local charities and causes. This ... coincides with the kickoff of the holiday shopping season. ... to shopping and Cyber Monday is to online commerce. ...
(Date:11/28/2014)... Dr. Diane Walder, one of the South ... Dr. Bridgit Nolan to her practice as a cosmetic ... her dermatology residency at the University of Miami Miller ... Nolan to join her practice because of her ... only does Dr. Nolan strive to provide the utmost ...
(Date:11/28/2014)... 2014 Dr. Diane Walder, one of ... treatment to her practice called Ultrashape that is designed to ... inches in just six weeks. Ultrashape has been praised by ... in results when compared to other types of external fat ... it,” said Dr. Walder. , According to Dr. Walder, ...
Breaking Medicine News(10 mins):Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2Health News:Car Accident Attorney Sean M. Cleary on Auto Insurance Policies Essential for Florida Drivers 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3
... Tampa, FL (Feb. 10, 2011) -- Preladenant, a non-dopaminergic ... receiving standard dopamine therapy, an international study led by ... of the double-blind, randomized clinical trial are reported online ... findings suggest that preladenant may offer a new supplemental ...
... More than two thousand physicians, some of ... in maternal-fetal medicine, especially high risk pregnancies, gathered ... to begin four days of intensive research presentations. ... Maternal-Fetal Medicine,s (SMFM) annual meeting, The Pregnancy Meeting ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... implanted device monitors fluid build-up in the lungs of heart ... As a result, the device reduces hospitalizations and improves quality ... the build-up of fluid pressure in the lungs that causes ...
... Ga. Regular exercise improves the ability of ... do math, Georgia Health Sciences University researchers report. ... 11-year-olds all sedentary when the study started - ... regular, vigorous physical activity is a part of every ...
... more than twice as likely to develop ulcers than people ... study from researchers at the University of Toronto. ... were abused during childhood and those were diagnosed with peptic ... Professor and Sandra Rotman Chair at U of T,s Factor-Inwentash ...
... EPA phased out the widespread residential use of chlorpyrifos ... risks to child neurodevelopment, these compounds were largely replaced ... replacement insecticides remained unclear, as they had never been ... the first study to examine the effects of these ...
Cached Medicine News:Health News:Non-dopaminergic drug preladenant reduces motor fluctuations in patients with Parkinson's disease 2Health News:SMFM highlights significance of spina bifida research findings 2Health News:Wireless Device Can Cut Heart Failure-Related Hospitalizations 2Health News:Wireless Device Can Cut Heart Failure-Related Hospitalizations 3Health News:Exercise helps overweight children think better, do better in math 2Health News:Common insecticide used in homes associated with delayed mental development of young children 2Health News:Common insecticide used in homes associated with delayed mental development of young children 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: